William Blair & Company’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,794
Closed -$19.8K 1830
2025
Q1
$19.8K Hold
12,794
﹤0.01% 1665
2024
Q4
$30.1K Sell
12,794
-2,138
-14% -$7.23K ﹤0.01% 1659
2024
Q3
$54.2K Sell
14,932
-3,862
-21% -$15.4K ﹤0.01% 1618
2024
Q2
$65.4K Sell
18,794
-313
-2% -$1.35K ﹤0.01% 1566
2024
Q1
$122K Sell
19,107
-8,000
-30% -$49.9K ﹤0.01% 1486
2023
Q4
$175K Buy
27,107
+14,000
+107% +$53.4K ﹤0.01% 1422
2023
Q3
$30.5K Hold
13,107
﹤0.01% 1638
2023
Q2
$31.2K Hold
13,107
﹤0.01% 1648
2023
Q1
$24.1K Sell
13,107
-234
-2% -$457 ﹤0.01% 1670
2022
Q4
$25.3K Hold
13,341
﹤0.01% 1659
2022
Q3
$29K Hold
13,341
﹤0.01% 1659
2022
Q2
$38K Hold
13,341
﹤0.01% 1655
2022
Q1
$56K Buy
13,341
+2,172
+19% +$9.13K ﹤0.01% 1697
2021
Q4
$58K Buy
+11,169
New +$67K ﹤0.01% 1759
2019
Q2
Sell
-12,000
Closed -$378K 1731
2019
Q1
$378K Sell
12,000
-9,600
-44% -$273K ﹤0.01% 1058
2018
Q4
$709K Sell
21,600
-9,200
-30% -$303K 0.01% 794
2018
Q3
$945K Buy
30,800
+22,000
+250% +$594K 0.01% 763
2018
Q2
$236K Buy
+8,800
New +$233K ﹤0.01% 1211

Other funds holding AUTL